PET/CT-based bone-marrow assessment shows potential in replacing routine bone-marrow biopsy in part of patients newly diagnosed with extranodal natural killer/T-cell lymphomaYiqin Wang, Ming Jiang, Hong Zhang et al.|Journal of Cancer Research and Clinical Oncology|2019Cited by 14
First line nucleos(t)ide analog monotherapy is more cost-effective than combination strategies in hepatitis B e antigen-positive chronic hepatitis B patients in ChinaXueru Yin, Jinlin Hou, Jidong Jia et al.|Chinese Medical Journal|2019Cited by 8